Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Xtreme One Entertainment Granted Summary Judgment; Court Orders Williamsburg Venture Holdings to Return 6.6 Million Shares Sold in Alleged Fraudulent Transfer of $XONI Stock